MULTIPLE SYSTEM ATROPHY
Clinical trials for MULTIPLE SYSTEM ATROPHY explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE SYSTEM ATROPHY trials appear
Sign up with your email to follow new studies for MULTIPLE SYSTEM ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ALT001 tested for rare brain disorder
Disease control Not yet recruitingThis early-phase study tests a new drug, ALT001, in 60 adults aged 30-75 with multiple system atrophy (MSA), a rare brain disease that affects movement and automatic body functions. The main goal is to check if the drug is safe and to see if it might help control symptoms. Partic…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: EARLY_PHASE1 • Sponsor: yilong Wang • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Could a common stroke drug help people with a rare brain disease?
Symptom relief Not yet recruitingThis study tests whether a drug called butylphthalide can improve symptoms of multiple system atrophy (MSA), a rare brain disorder. About 150 adults with MSA will take either the drug or a placebo for 6 months. Researchers will measure changes in movement and daily function to se…
Matched conditions: MULTIPLE SYSTEM ATROPHY
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 17, 2026 09:08 UTC